FIRST SESSION: State of the art Chairs: Volker Schuster and Carlo Giaquinto 9:00 Welcome and Opening Michael Borte, Hans-Iko Huppertz, Volker Schuster 9.10 Rotavirus infecon and vaccinaon: basic facts Hans-Iko Huppertz 9.30 Progress in expansion of rotavirus vaccinaon in Europe since the 2 nd expert meeng in 2011 Timo Vesikari 9.50 Update on effecveness and use of pentavalent rotavirus vaccine, RotaTeq tba 10.10 Update on effecveness and use of human rotavirus vaccine, Rotarix tba 10.30 Coffee Break SECOND SESSION: Special Topics Chairs: Michael Borte and Timo Vesikari 11.00 Expansion of rotavirus vaccinaon in GAVI-eligible countries Duncan Steele 11.20 Porcine circovirus update Federico Marnón-Torres 11.40 Intussuscepon surveillance in the Americas Manish Patel 12.10 Intussuscepon reporng in Europe Doris Oberle 12.30 Lunch THIRD SESSION: Experience with RV universal mass vaccinaon (UMV) Chairs: Hans-Iko Huppertz and Philippe Lepage 13.30 Unexpected benefits of RV vaccinaon in the US Roger Glass FIFTH SESSION: Current Research (1) Chair: Hans-Iko Huppertz 09.00 Molecular epidemiology of rotavirus aſter UMV in Belgium Jelle Mahijnssens 09.20 RotaTeq double reassortants in vaccine recipients Maria Hemming 09.35 Rotaviruses in Brazil Marco Sáfadi (tbc) 09.50 Resurrecon of RotaShield George Armah 10.10 RV in infants with immunodeficiency (including HIV) Carlo Giaquinto 10.30 Coffee Break SIXTH SESSION: Current Research (2) Chairs: Michael Borte and Pierre van Damme 11.00 RV vaccines in neonates and prematures Pierre van Damme 11.20 Prevenon of nosocomial RV infecon Patricia Bruijning-Verhagen 11.40 Lactobacillus-mediated protecon against rotavirus infecon Lennart Hammarström 12.00 Health economics and cost effecveness tba 12.30 Closing remarks Michael Borte, Hans-Iko Huppertz, Volker Schuster 12.40 Lunch and Departures 13.50 Success of rotavirus UMV in Europe: Austria tba Belgium Philippe Lepage Finland Timo Vesikari Israel Ron Dagan 14.10 Impact of rotavirus vaccinaon on reducing hospitalizaons and deaths from diarrhea in Lan America Umesh Parashar 14.20 Experience of RV vaccinaon in German Federal States Michael Borte, Volker Schuster, Dietmar Beier, Holm Uhlig, Petra Kaiser 15.30 Coffee Break FOURTH SESSION: Way forward in Europe Chairs: Volker Schuster 16.00 Status of introducon of RV UMV in Greece Vana Sponlou Latvia Dace Zavadska Norway Synne Sandbu 16.30 RV Vaccinaon in Eastern Europe Poland tba Hungary Sophia Meszner Overall picture and comparison in Central and Eastern European countries Roman Prymula Rotavirus Surveillance Network (Georgia, Tajikistan and Ukraine) Duncan Steele 17.15 Panel Discussion: Overcoming hurdles for rotavirus UMV in European countries Carlo Giaquinto (Chair), Adam Finn, Hans-Iko Huppertz, Philippe Lepage 20.00 Social Evening at the Leipzig Zoo Tuesday, 23 April 2013 Wednesday, 24 April 2013 Local Organizers Prof. Dr. Michael Borte Phone: +49-341-9093604 E-Mail: Michael.Borte@ sanktgeorg.de Prof. Dr. Hans-Iko Huppertz Phone: +49-421-497-5411 E-Mail: hans-iko.huppertz@ med.uni-goengen.de Prof. Dr. Volker Schuster Phone: +49-341-9726844 E-Mail: volker.schuster@ medizin.uni-leipzig.de Venue Leipziger KUBUS – Das Konferenz- und Bildungszentrum des UFZ Permoserstraße 15 04318 Leipzig/Germany www.rotavirus-leipzig.de Conference Office event lab. GmbH Dufourstraße 15 04107 Leipzig/Germany Project Management: Nancy Klein E-Mail: [email protected] Phone: +49-341-240596-60 www.eventlab.org Conference Fees Regular Participants: 80,00 EUR (incl. 19% VAT) Students: 40,00 EUR (incl. 19% VAT) !